Literature DB >> 1582251

A microchromosome derived from chromosome 11 in a patient with the CREST syndrome of scleroderma.

T Haaf1, A T Sumner, J Köhler, H F Willard, M Schmid, A T Summer.   

Abstract

A patient with the CREST syndrome of scleroderma was found to carry a mosaicism for a supernumerary microchromosome. The microchromosome was approximately 1 micron in size and present in over half of the lymphocyte metaphases examined. It bound centromeric proteins specifically recognized by CREST autoimmune sera (including the patient's serum). In situ hybridization with a panel of chromosome-specific alpha-satellite probes showed that the microchromosome was derived from chromosome 11, most or all of its chromatin consisting of the chromosome 11 subset of alpha-satellite DNA. It had no detectable telomeric sequences. Microchromosomes observed by electron microscopy had no visible free ends. The chromatin looked exactly the same as it did in normal chromosomes. Although we have no direct evidence for a circular structure, we conclude that the microchromosome originated by an interstitial deletion including the alpha-satellite DNA sequences and subsequent ring formation. The newly formed chromosomal element proved to be relatively stable somatically and was transmitted through meiosis. Since it possesses at least some structural and functional features of a centromeric region, the microchromosome can be thought of as an isolated centromere.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582251     DOI: 10.1159/000133284

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  2 in total

1.  Islands of complex DNA are widespread in Drosophila centric heterochromatin.

Authors:  M H Le; D Duricka; G H Karpen
Journal:  Genetics       Date:  1995-09       Impact factor: 4.562

2.  Centromeric association of a microchromosome in a Turner syndrome patient with a pseudodicentric Y.

Authors:  H Rivera; M G Domínguez; A I Vásquez; A L Ramos; R Fragoso
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.